Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force von MARTINOWITZ, U., MICHAELSON, M.

Volltext

The effect of fibrinogen concentrate on thrombocytopenia von VELIK‐SALCHNER, C., HAAS, T., INNERHOFER, P., STREIF, W., NUSSBAUMER, W., KLINGLER, A., KLIMA, G., MARTINOWITZ, U., FRIES, D.

Volltext

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety... von Lentz, S. R., Misgav, M., Ozelo, M., Šalek, S. Z., Veljkovic, D., Recht, M., Cerqueira, M., Tiede, A., Brand, B., Mancuso, M. E., Seremetis, S., Lindblom, A., Martinowitz, U.

Volltext

Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients von Martinowitz, U., Lissitchkov, T., Lubetsky, A., Jotov, G., Barazani-Brutman, T., Voigt, C., Jacobs, I., Wuerfel, T., Santagostino, E.

Volltext

Treatment of traumatic bleeding with recombinant factor VIIa von Kenet, Gili, Walden, Raphael, Eldad, Arieh, Martinowitz, Uri

Volltext

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®) von Kenet, G., Lubetsky, A., Luboshitz, J., Martinowitz, U.

Volltext

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children von Kenet, G, Sadetzki, S, Murad, H, Martinowitz, U, Rosenberg, N, Gitel, S, Rechavi, G, Inbal, A

Volltext

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS von Lalezari, S., Martinowitz, U., Windyga, J., Enriquez, M. M., Delesen, H., Schwartz, L., Scharrer, I.

Volltext

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors von MARTINOWITZ, U., LIVNAT, T., ZIVELIN, A., KENET, G.

Volltext

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemoph... von MARTINOWITZ, U., BJERRE, J., BRAND, B., KLAMROTH, R., MISGAV, M., MORFINI, M., SANTAGOSTINO, E., TIEDE, A., VIUFF, D.

Volltext

Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- a... von Shenkman, B., Einav, Y., Livnat, T., Budnik, I., Martinowitz, U.

Volltext

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors - a thrombin generation-guided pilot study von Livnat, T., Martinowitz, U., Azar-Avivi, S., Zivelin, A., Brutman-Barazani, T., Lubetsky, A., Kenet, G.

Volltext

Efficacy and safety of prophylaxis with once-weekly BAY 79–4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients von Powell, Jerry, Martinowitz, Uri, Windyga, Jerzy, Di Minno, Giovanni, Hellmann, Andrzej, Pabinger, Ingrid, Enriquez, Monika Maas, Schwartz, Lawrence, Ingerslev, Jørgen

Volltext

Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery von Batorova, Angelika, Martinowitz, Uri

Volltext

Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhage von White, N. J., Mehic, E., Wang, X., Chien, D., Lim, E., St. John, A. E., Stern, S. A., Mourad, P. D., Rieger, M., Fries, D., Martinowitz, U.

Volltext

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma von LIVNAT, T., MARTINOWITZ, U., ZIVELIN, A., SELIGSOHN, U.

Volltext

Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centr... von Kenet, Gili, Stenmo, Camilla B., Blemings, Allan, Wegert, Wolfgang, Goudemand, Jenny, Krause, Manuela, Schramm, Wolfgang, Kirchmaier, Carl, Martinowitz, Uri

Volltext

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study von STRAUSS, T., LUBETSKY, A., RAVID, B., BASHARI, D., LUBOSHITZ, J., LALEZARI, S., MISGAV, M., MARTINOWITZ, U., KENET, G.

Volltext

Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI von LIVNAT, T., ZIVELIN, A., MARTINOWITZ, U., SALOMON, O., SELIGSOHN, U.

Volltext

450 THE NATURAL HISTORY OF HEPATITIS C-INFECTED HEMOPHILIA PATIENTS – DOES TREATMENT MATTER? von Maor, Y, Schapiro, J.M, Bashari, D, Martinowitz, U

Volltext